Live Oak Health Sciences Fund
LOGSX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Live Oak Health Sciences Fund (LOGSX) is a sector-specific mutual fund that seeks long-term capital growth by investing primarily in common stocks of U.S. companies engaged in the research, development, production, or distribution of products and services related to biotechnology, health services, medicine, and life sciences; it normally allocates at least 80% of its net assets to equity securities of such health science companies, focusing on large- and mid-capitalization issuers while permitting investments across all market capitalizations. The fund employs a disciplined investment approach that combines top-down sector analysis to identify compelling opportunities within health sciences with bottom-up stock selection emphasizing quantitative and qualitative assessments of company fundamentals, including valuation, earnings growth potential, competitive advantages, and management quality; portfolio construction prioritizes low turnover relative to peers and long-term holding periods to capitalize on technological advances, innovative changes, and demographic trends in the healthcare industry. To a limited extent, the fund may also invest in equity REITs, common stocks of foreign companies, and American Depositary Receipts (ADRs) that align with its health sciences criteria. Launched on June 29, 2001, by Oak Associates Ltd., headquartered in Bath, Ohio, the fund operates within the broader U.S. healthcare equity segment, targeting institutional investors, financial advisors, endowments, foundations, pension plans, and individual shareholders through its Class I shares, which carry a total annual operating expense ratio of 1.03% following contractual fee waivers. Oak Associates, founded in 1985, manages the fund as part of its suite of seven mutual funds and additional SMA and institutional strategies emphasizing concentrated, low-turnover U.S. equity portfolios. No major strategic changes, such as partnerships, acquisitions, funding rounds, new product launches, or operational reorganizations, have been reported for the fund in the last 1-2 years; it continues to adhere to its established long-term investment philosophy amid ongoing management by the firm's experienced team.